Literature DB >> 31948979

Rare case of bilateral wrist and foot drop from SLE-related vasculitic polyneuropathy.

Soujanya Sodavarapu1, Rajani Rudrangi2, Jeffrey Hoffman3.   

Abstract

Systemic lupus erythematosus (SLE) is a heterogeneous, chronic, inflammatory, autoimmune disease characterised by multiorgan involvement and the production of multiple autoantibodies. Neurological manifestations in SLE patients are frequently reported-the prevalence is 37%-90%. We present a unique case where the patient presented with bilateral wrist and foot drop for 4 days, which later led to the diagnosis of SLE-related vasculitic polyneuropathy. During the course of treatment, the patient received prednisone, rituximab and hydroxychloroquine. At 6-month follow-up, patient had reported significant improvement in her weakness with increased mobility in upper and lower extremities. Prompt diagnosis and treatment are necessary in these cases to prevent disease progression and morbidity. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  peripheral nerve disease; systemic lupus erythematosus; vasculitis

Mesh:

Year:  2020        PMID: 31948979      PMCID: PMC7035861          DOI: 10.1136/bcr-2019-232890

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Authors:  George Bertsias; Dimitrios T Boumpas; Antonis Fanouriakis; Myrto Kostopoulou; Alessia Alunno; Martin Aringer; Ingeborg Bajema; John N Boletis; Ricard Cervera; Andrea Doria; Caroline Gordon; Marcello Govoni; Frédéric Houssiau; David Jayne; Marios Kouloumas; Annegret Kuhn; Janni L Larsen; Kirsten Lerstrøm; Gabriella Moroni; Marta Mosca; Matthias Schneider; Josef S Smolen; Elisabet Svenungsson; Vladimir Tesar; Angela Tincani; Anne Troldborg; Ronald van Vollenhoven; Jörg Wenzel
Journal:  Ann Rheum Dis       Date:  2019-03-29       Impact factor: 19.103

Review 2.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

Review 3.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

4.  Peripheral neuropathy in patients with systemic lupus erythematosus.

Authors:  Brandusa Florica; Ellie Aghdassi; Jiandong Su; Dafna D Gladman; Murray B Urowitz; Paul R Fortin
Journal:  Semin Arthritis Rheum       Date:  2011-10       Impact factor: 5.532

5.  Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.

Authors:  F Dammacco; O Della Casa Alberighi; G Ferraccioli; V Racanelli; L Casatta; E Bartoli
Journal:  Int J Clin Lab Res       Date:  2000

Review 6.  Autoantibodies to intracellular antigens: generation and pathogenetic role.

Authors:  Vito Racanelli; Marcella Prete; Gerta Musaraj; Franco Dammacco; Federico Perosa
Journal:  Autoimmun Rev       Date:  2011-03-22       Impact factor: 9.754

7.  Mononeuritis multiplex complicating systemic lupus erythematosus.

Authors:  Arijit Bhowmik; Prabhabati Banerjee
Journal:  Indian Pediatr       Date:  2012-07       Impact factor: 1.411

Review 8.  Pragmatic approaches to therapy for systemic lupus erythematosus.

Authors:  Wen Xiong; Robert G Lahita
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

9.  Pattern-recognition approach to neuropathy and neuronopathy.

Authors:  Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

10.  Peripheral neuropathies due to systemic lupus erythematosus in China.

Authors:  Wang Xianbin; Wang Mingyu; Xu Dong; Li Huiying; Xu Yan; Zhang Fengchun; Zeng Xiaofeng
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.